Table 4.

Risk of all-cause death and major adverse cardiovascular events for men and women with type 2 myocardial infarction

	HR (95% CI)	P value
All-cause death* (men, ref cat)
Model 1 (crude)	0.82 (0.75 to 0.90)	<0.001
Model 2 (model 1+adjusted for comorbidities)	0.81 (0.74 to 0.90)	<0.001
Model 3 (model 2+adjusted for hs-cTnT concentrations)	0.84 (0.76 to 0.92)	≤0.001
Major adverse cardiovascular events† (men, ref cat)
Model 1 (crude)	0.87 (0.80 to 0.95)	0.002
Model 2 (model 1+adjusted for comorbidities)	0.92 (0.84 to 1.01)	0.067
Model 3 (model 2+adjusted for hs-cTnT concentrations)	0.94 (0.86 to 1.03)	0.189

Model 1: sex, hospital site, year; model 2: model 1+age, current smoking, hypertension, diabetes, hyperlipidaemia, coronary artery disease, congestive heart failure, previous stroke, ST-segment depression, estimated glomerular filtration rate, COPD, dementia, previous or present cancer; model 3: model 2+hs-cTnT levels.

*Patients with type 2 myocardial infarction, n=4119.

†Patients with type 2 myocardial infarction, n=3979.

COPD, chronic obstructive pulmonary disease; hs-cTnT, high-sensitivity cardiac troponin T; ref cat, reference category.